Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System

Journal of the American Academy of Dermatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles